DAFNA Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Buy |
191,493
+21,497
| +13% | +$344K | 0.85% | 30 |
|
|
2025
Q1 | $2.91M | Buy |
169,996
+62,000
| +57% | +$1.06M | 0.82% | 32 |
|
|
2024
Q4 | $2.68M | Buy |
107,996
+56,000
| +108% | +$1.39M | 0.68% | 32 |
|
|
2024
Q3 | $1.48M | Buy |
51,996
+4,080
| +9% | +$116K | 0.35% | 55 |
|
|
2024
Q2 | $1.26M | Buy |
47,916
+18,500
| +63% | +$488K | 0.3% | 57 |
|
|
2024
Q1 | $950K | Sell |
29,416
-11,326
| -28% | -$366K | 0.22% | 60 |
|
|
2023
Q4 | $1.72M | Buy |
40,742
+18,242
| +81% | +$769K | 0.41% | 46 |
|
|
2023
Q3 | $864K | Buy |
+22,500
| New | +$864K | 0.27% | 61 |
|